Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Elekta’s VMAT radiation therapy receives FDA 510(k)

Elekta : 16 June, 2008  (New Product)
Elekta’s VMAT solution has received FDA 510(k) clearances that will allow US cancer specialists to both plan and deliver radiation using a technique which has the potential to boost the practice of radiation oncology.
From the patient's perspective, Elekta VMAT (Volumentric intensty Modulated Arc Therapy) combines a significant reduction in treatment time with optimal avoidance of radiation dose to healthy tissues surrounding the tumour.

From the doctor's perspective, the reduction in treatment time makes it much easier to accurately target the tumour and the improved dose sparing offers new options to either increase dose to tumour or reduce side effects and therefore potentially improve outcomes. For the clinic administrator, reduced treatment times and the opportunity to increase dose and reduce the number of treatment sessions increases the number of patients that can be treated using their existing equipment.

Elekta is positioned to introduce the VMAT technique by virtue of Elekta Synergy, the only fully digital linear accelerator with integrated high-resolution 3D X-ray Volume Imaging (XVI). With daily pre-treatment imaging scans, clinicians who implement Elekta VMAT will be able to maximize accuracy and shrink treatment margins, while minimizing the possibility of damage to surrounding healthy tissue.

“Over ten years of research in collaboration with members of the Elekta IMRT Consortium has led to this unique series of innovations”, explained Tomas Puusepp, president and chief executive officer of Elekta. “Having the worlds only fully digital accelerator is a key element in making this level of automation and control complexity possible in a way that allows clinicians to deliver advanced treatments with a single push of a button. Interest from clinicians in this technology is very high and we believe that VMAT will be the next major technology shift following the introduction of intensity modulated radiation therapy (IMRT) around the millennium and the subsequent introduction of image guided radiation therapy (IGRT)”, concluded Tomas Puusepp.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo